Interobserver variability in tumor contouring affects the use of radiomics to predict mutational status.

about

Interobserver variability in tumor contouring affects the use of radiomics to predict mutational status.

Item

http://www.wikidata.org/entity/Q52446289

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Interobserver variability in t ...... to predict mutational status.

@en

Interobserver variability in t ...... to predict mutational status.

@nl

type

Item

label

Interobserver variability in t ...... to predict mutational status.

@en

Interobserver variability in t ...... to predict mutational status.

@nl

prefLabel

Interobserver variability in t ...... to predict mutational status.

@en

Interobserver variability in t ...... to predict mutational status.

@nl

P1476

Interobserver variability in t ...... to predict mutational status.

@en

P2093

Binsheng Zhao

http://www.w3.org/2001/XMLSchema#string

Lawrence Schwartz

http://www.w3.org/2001/XMLSchema#string

Lin Lu

http://www.w3.org/2001/XMLSchema#string

Min Zong

http://www.w3.org/2001/XMLSchema#string

Philip Lichtenstein

http://www.w3.org/2001/XMLSchema#string

Qian Yin

http://www.w3.org/2001/XMLSchema#string

Qiao Huang

http://www.w3.org/2001/XMLSchema#string

Yajun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society 1

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Reduced lung-cancer mortality with low-dose computed tomographic screening

Test-retest reproducibility analysis of lung CT image features

Cancer statistics, 2016

Screening for epidermal growth factor receptor mutations in lung cancer

Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer.

P304

011005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1117/1.JMI.5.1.011005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laurent Dercle

P577

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29098170

http://www.w3.org/2001/XMLSchema#string

P932

5650105

http://www.w3.org/2001/XMLSchema#string